Biogen Inc/ US09062X1037 /
| 2024-11-07 5:39:09 PM | Chg. -0.0100 | Volume | Bid5:39:16 PM | Ask5:39:16 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 174.3900USD | -0.01% | 270,457 Turnover: 31.54 mill. |
174.3400Bid Size: 100 | 174.5200Ask Size: 800 | 25.41 bill.USD | - | 21.74 |
Assets
| 2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 2,187.6000 | 2,501.8000 | 3,182.4000 | 3,601.2000 | 3,247.3000 | ||||||
| Intangible Assets | 4,085.1000 | 3,808.3000 | 3,879.6000 | 3,120 | 3,527.4000 | ||||||
| Long-Term Investments | 2,760.4000 | 2,829.4000 | 3,057.3000 | 1,375.9000 | 1,408.1000 | ||||||
| Fixed Assets | 12,804.5000 | 14,144.6000 | 15,779.3000 | 17,648 | 18,852.5000 | ||||||
| Inventories | 893.4000 | 1,001.6000 | 902.7000 | 929.9000 | 804.2000 | ||||||
| Accounts Receivable | 1,227 | 1,441.6000 | 1,787 | 1,958.5000 | 1,880.5000 | ||||||
| Cash and Cash Equivalents | 1,308 | 2,326.5000 | 1,573.8000 | 1,224.6000 | 2,913.7000 | ||||||
| Current Assets | 6,700.3000 | 8,732.2000 | 7,873.3000 | 7,640.9000 | 8,381.8000 | ||||||
| Total Assets | 19,504.8000 | 22,876.8000 | 23,652.6000 | 25,288.9000 | 27,234.3000 | ||||||
Liabilities
| 2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 267.4000 | 279.8000 | 395.5000 | 370.5000 | 530.8000 | ||||||
| Long-term debt | 6,521.5000 | 6,512.7000 | 5,935 | 5,936.5000 | 4,459 | ||||||
| Liabilities to Banks | 6,521.5000 | 6,512.7000 | 5,935 | 5,936.5000 | 4,459 | ||||||
| Provisions | 333.6000 | 325 | 190.8000 | 1,699.7000 | 2,882.2000 | ||||||
| Liabilities | 10,129.9000 | 10,748.2000 | 11,054.5000 | 12,257.3000 | 13,895.2000 | ||||||
| Share Capital | .1000 | .1000 | .1000 | .1000 | .1000 | ||||||
| Total Equity | 9,374.9000 | 12,128.6000 | 12,598.1000 | 13,031.6000 | 13,339.1000 | ||||||
| Minority Interests | 2.1000 | -11.5000 | -14.7000 | -8 | -4.1000 | ||||||
| Total liabilities equity | 19,504.8000 | 22,876.8000 | 23,652.6000 | 25,288.9000 | 27,234.3000 | ||||||
Income Statement
| 2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 10,763.8000 | 11,448.8000 | 12,273.9000 | 13,452.9000 | 14,377.9000 | ||||||
| Depreciation (total) | 600.4000 | 682.7000 | 1,081 | 1,016.6000 | 680.6000 | ||||||
| Operating Result | 4,891 | 5,150.4000 | 5,344.2000 | 5,888.6000 | 7,042.6000 | ||||||
| Interest Income | -73.4000 | -196.6000 | -172.3000 | -88.1000 | -67.4000 | ||||||
| Income Before Taxes | 4,767.3000 | 4,933 | 5,128.8000 | 5,899.6000 | 7,125.9000 | ||||||
| Income Taxes | 1,161.6000 | 1,237.3000 | 2,458.7000 | 1,425.6000 | 1,158 | ||||||
| Minority Interests Profit | 46.2000 | -7.1000 | 131 | 43.3000 | 0.0000 | ||||||
| Net Income | 3,547 | 3,702.8000 | 2,539.1000 | 4,430.7000 | 5,888.5000 | ||||||
Per Share
Cash Flow
| 2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 3,716.1000 | 4,522.4000 | 4,551 | 6,187.7000 | 7,078.6000 | ||||||
| Cash Flow from Investing Activities | -4,553.6000 | -2,484.8000 | -2,963.1000 | -2,046.3000 | 470.5000 | ||||||
| Cash Flow from Financing | 986.4000 | -987.8000 | -2,380 | -4,472 | -5,860.4000 | ||||||
| Decrease / Increase in Cash | 148.9000 | 1,049.8000 | -792.1000 | -330.6000 | 1,688.7000 | ||||||
| Employees | 7,350 | 7,400 | 7,300 | 7,800 | 7,400 | ||||||
